United States · 
Who invested in BioEclipse Therapeutics?
BioEclipse Therapeutics's investors include Revelis Capital Group, TSVC, DEFTA Partners, Plum Alley and Tsingyuan Ventures. Revelis Capital Group led its latest round.
United States · Series A startup
Who invested in BioEclipse Therapeutics
Funding summaryUpdated 26 Oct 2026
$7.7Mraised across 1 round since 2019, from 1 source
- Latest round
- Series A, $7.7MJun 2019
- Led by
- Revelis Capital Group
- Investors
- 5 (1 led)
The rounds
- Jun 2019Series A$7.7M
Reported by FinSMEsSEC filing: $7.8M sold, first sale Jun 2019
Founders and team
From the SEC filings it signed: 3 on the team.
- Benjamin CarterExecutive Officeri
- Pamela Reilly ContagExecutive Officer, Directori
- Stephen ThauExecutive Officeri
On the board, as filediBiao HeCatherine SohnElona BaumGregory SchiffmanMark Frohlich
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists BioEclipse Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about BioEclipse Therapeutics
How much has BioEclipse Therapeutics raised?
BioEclipse Therapeutics has raised $7.7M across 1 round since 2019.
When did BioEclipse Therapeutics last raise?
BioEclipse Therapeutics's most recent round was a Series A of $7.7M in Jun 2019, led by Revelis Capital Group.
What was BioEclipse Therapeutics's biggest round?
Its most recent round, $7.7M in Jun 2019, is also its largest on record.
Who backed BioEclipse Therapeutics first?
BioEclipse Therapeutics's first round on record, in Jun 2019, was backed by Revelis Capital Group, TSVC and DEFTA Partners and 2 others.
What stage is BioEclipse Therapeutics at?
BioEclipse Therapeutics's latest named round is a Series A, in Jun 2019.
Where is BioEclipse Therapeutics based?
BioEclipse Therapeutics is based in the United States.
Who led BioEclipse Therapeutics's rounds?
Revelis Capital Group led the Series A in 2019.
Companies like BioEclipse Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.